Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot P03472 (NRAM_I75A5)

Last modified June 10, 2008. Version 83. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (4) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesNeuraminidase
Also known as:
     EC 3.2.1.18
Gene names
Name: NA
OrganismInfluenza A virus (strain A/Tern/Australia/G70C/1975 H11N9)
Taxonomic identifier384509 [NCBI]
Taxonomic lineageVirusesssRNA negative-strand virusesOrthomyxoviridaeInfluenzavirus A
Virus hostAves [TaxID: 8782]
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Catalyzes the removal of terminal sialic acid residues from viral and cellular glycoconjugates. Cleaves off the terminal sialic acids on the glycosylated HA during virus budding to facilitate virus release. Additionally helps virus spread through the circulation by further removing sialic acids from the cell surface. These cleavages prevent self-aggregation and ensure the efficient spread of the progeny virus from cell to cell. Otherwise, infection would be limited to one round of replication. Described as a receptor-destroying enzyme because it cleaves a terminal sialic acid from the cellular receptors. May facilitate viral invasion of the upper airways by cleaving the sialic acid moities on the mucin of the airway epithelial cells. Likely to plays a role in the budding process through its association with lipid rafts during intracellular transport. May additionally display a raft-association independent effect on budding. Plays a role in the determination of host range restriction on replication and virulence. Sialidase activity in late endosome/lysosome traffic seems to enhance virus replication.

Catalytic activity

Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-(2->8)- glycosidic linkages of terminal sialic acid residues in oligosaccharides, glycoproteins, glycolipids, colominic acid and synthetic substrates.

Cofactor

Binds 1 calcium ion By similarity.

Enzyme regulation

Inhibited by the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir (Tamiflu). These drugs interfere with the release of progeny virus from infected cells and are effective against all influenza strains. Resistance to neuraminidase inhibitors is quite rare.

Subunit structure

Homotetramer By similarity.

Subcellular location

Virion membrane By similarity. Apical cell membrane; Single-pass type II membrane protein By similarity. Note=Preferentially accumulates at the apical plasma membrane in infected polarized epithelial cells, which is the virus assembly site. Uses lipid rafts for cell surface transport and apical sorting. In the virion, forms a mushroom-shaped spike on the surface of the membrane By similarity.

Domain

Intact N-terminus is essential for virion morphogenesis. Possess two apical sorting signals, one in the ectodomain, which is likely to be a glycan, and the other in the transmembrane domain. The transmembrane domain also plays a role in lipid raft association By similarity.

Post-translational modification

N-glycosylated By similarity.

Miscellaneous

The influenza A genome consist of 8 RNA segments. Genetic variation of hemagglutinin and/or neuraminidase genes results in the emergence of new influenza strains. The mechanism of variation can be the result of point mutations or the result of genetic reassortment between segments of two different strains.

Sequence similarities

Belongs to the glycosyl hydrolase 34 family.

Ontologies

Keywords

   Cellular componentMembrane
Virion
   DomainSignal-anchor
Transmembrane
   LigandCalcium
Metal-binding
   Molecular functionGlycosidase
Hydrolase
   PTMGlycoprotein
   Technical term3D-structure

Gene Ontology (GO)

   Cellular componentapical plasma membrane

Inferred from electronic annotation. Source: UniProtKB-SubCell

virion membrane

Inferred from electronic annotation. Source: UniProtKB-SubCell

Complete GO annotation...

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical view

Molecule processing

Chain1 – 470470Neuraminidase

Regions

Topological domain1 – 66Cytoplasmic Potential
Transmembrane7 – 3529Signal-anchor for type II membrane protein Potential
Topological domain36 – 470435Extracellular Potential
Region11 – 3323Involved in apical transport and lipid raft association By similarity
Region36 – 9156Hypervariable stalk region
Region92 – 470379Head of neuraminidase
Compositional bias345 – 3484Poly-Asn

Sites

Active site1521 Potential
Active site2781 Potential
Active site4061 Potential
Metal binding2951Calcium (via carbonyl oxygen) By similarity
Metal binding2991Calcium (via carbonyl oxygen) By similarity
Metal binding3261Calcium By similarity
Metal binding3481Calcium (via carbonyl oxygen) By similarity
Binding site1191Substrate Potential
Binding site2941Substrate Potential
Binding site3721Substrate Potential

Amino acid modifications

Glycosylation631N-linked (GlcNAc...) Potential
Glycosylation661N-linked (GlcNAc...) Potential
Glycosylation871N-linked (GlcNAc...)
Glycosylation1471N-linked (GlcNAc...)
Glycosylation2021N-linked (GlcNAc...)
Disulfide bond93 ↔ 419
Disulfide bond125 ↔ 130
Disulfide bond177 ↔ 195
Disulfide bond185 ↔ 232
Disulfide bond234 ↔ 239
Disulfide bond280 ↔ 293
Disulfide bond282 ↔ 291
Disulfide bond320 ↔ 338
Disulfide bond423 ↔ 449

Experimental info

Sequence conflict3771M → I in AAA43574. Ref.2
Sequence conflict387 – 3882DK → ER in AAA43574. Ref.2

Secondary structure

.................................................................. 470
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
P03472-1 [UniParc].

Last modified July 21, 1986. Version 1.
Checksum: F114226CF93E1370

FASTA47052,469
        10         20         30         40         50         60 
MNPNQKILCT SATALVIGTI AVLIGITNLG LNIGLHLKPS CNCSHSQPEA TNASQTIINN 

        70         80         90        100        110        120 
YYNDTNITQI SNTNIQVEER AIRDFNNLTK GLCTINSWHI YGKDNAVRIG EDSDVLVTRE 

       130        140        150        160        170        180 
PYVSCDPDEC RFYALSQGTT IRGKHSNGTI HDRSQYRALI SWPLSSPPTV YNSRVECIGW 

       190        200        210        220        230        240 
SSTSCHDGKT RMSICISGPN NNASAVIWYN RRPVTEINTW ARNILRTQES ECVCHNGVCP 

       250        260        270        280        290        300 
VVFTDGSATG PAETRIYYFK EGKILKWEPL AGTAKHIEEC SCYGERAEIT CTCRDNWQGS 

       310        320        330        340        350        360 
NRPVIRIDPV AMTHTSQYIC SPVLTDNPRP NDPTVGKCND PYPGNNNNGV KGFSYLDGVN 

       370        380        390        400        410        420 
TWLGRTISIA SRSGYEMLKV PNALTDDKSK PTQGQTIVLN TDWSGYSGSF MDYWAEGECY 

       430        440        450        460        470 
RACFYVELIR GRPKEDKVWW TSNSIVSMCS STEFLGQWDW PDGAKIEYFL 

« Hide

References

[1]"Gene and protein sequence of an influenza neuraminidase with hemagglutinin activity."
Air G.M., Ritchie L.R., Laver W.G., Colman P.M.
Virology 145:117-122(1985) [PubMed: 4013081] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC RNA].
[2]"Distribution of sequence differences in influenza N9 neuraminidase of tern and whale viruses and crystallization of the whale neuraminidase complexed with antibodies."
Air G.M., Webster R.G., Colman P.M., Laver W.G.
Virology 160:346-354(1987) [PubMed: 3660585] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC RNA].
[3]"Assembly and budding of influenza virus."
Nayak D.P., Hui E.K., Barman S.
Virus Res. 106:147-165(2004) [PubMed: 15567494] [Abstract]
Cited for: REVIEW.
[4]"Neuraminidase inhibitors for influenza."
Moscona A.
N. Engl. J. Med. 353:1363-1373(2005) [PubMed: 16192481] [Abstract]
Cited for: REVIEW.
[5]"Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses."
Suzuki Y.
Biol. Pharm. Bull. 28:399-408(2005) [PubMed: 15744059] [Abstract]
Cited for: REVIEW.
[6]"Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus."
Baker A.T., Varghese J.N., Laver W.G., Air G.M., Colman P.M.
Proteins 2:111-117(1987) [PubMed: 3447170] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 83-470.
[7]"Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid."
Bossart-Whitaker P., Carson M., Babu Y.S., Smith C.D., Laver W.G., Air G.M.
J. Mol. Biol. 232:1069-1083(1993) [PubMed: 8371267] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 83-470.
[8]"Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases."
Varghese J.N., Colman P.M., van Donkelaar A., Blick T.J., Sahasrabudhe A., McKimm-Breschkin J.L.
Proc. Natl. Acad. Sci. U.S.A. 94:11808-11812(1997) [PubMed: 9342319] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 83-470.

Cross-references

Sequence databases

M11445 Genomic RNA. Translation: AAA43353.1.
M17813 Genomic RNA. Translation: AAA43574.1.
PIRNMIV9. A00884.

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
1A14X-ray2.50N83-470[»]
1BJIX-ray2.00A83-470[»]
1F8BX-ray1.80A83-470[»]
1F8CX-ray1.70A83-470[»]
1F8DX-ray1.40A83-470[»]
1F8EX-ray1.40A83-470[»]
1INYX-ray2.40A83-470[»]
1L7FX-ray1.80A83-470[»]
1L7GX-ray1.85A83-470[»]
1L7HX-ray1.85A83-470[»]
1MWEX-ray1.70A83-470[»]
1NCAX-ray2.50N82-470[»]
1NCBX-ray2.50N82-470[»]
1NCCX-ray2.50N82-470[»]
1NMCX-ray2.50A/N83-470[»]
1NNAX-ray2.50A84-470[»]
1NNBX-ray2.80A84-470[»]
1NNCX-ray1.80A83-470[»]
1XOEX-ray2.20A84-470[»]